#remission

The study findings underscore the importance of starting antiretroviral therapy as soon as possible.

After advances in HIV therapy, long-acting antiretrovirals and long-term remission are the next frontiers.

One person treated with a broadly neutralizing antibody plus romidepsin remained in remission for 3.7 years.

A combination of two antibodies, dubbed 3BNC117 and 10-1074, maintained viral suppression for a year in two people.

The woman’s leukemia is in remission and she remains free of detectable HIV more than a year after stopping antiretroviral treatment.

People whose HIV is locked away in “gene deserts” might be able to interrupt treatment without viral rebound.

COVID-19, HIV vaccine and cure news, and long-acting HIV treatment and prevention topped the news again this year.

The updated report summarizes progress to date, identifies gaps and outlines recommendations for HIV cure research over the next five years.

One new approach protects CD4 cells against HIV entry, while another snips out viral genes in infected cells.

Different mechanisms suppressed the virus in each person.

A man with HIV is in long-term viral remission after intensified treatment.

Researchers project the Brazilian man could become the first person deemed cured of HIV without a bone marrow transplant.

A second man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.

“The Düsseldorf Patient” has been off HIV meds only since November 2018, so it is much too early to determine whether he has been cured.

Perhaps amfAR sums it up best: “We’re certainly hopeful.”

Timothy Brown may have company after a man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.